STONKWHISPER
← Back to Intel
Insider ActivityTNGX

Crystal Adam, President, R&D at Tango Therapeutics, Inc., sold $572K of TNGX

Updated Jun 14, 2026
Crystal Adam President, R&D
Tango Therapeutics, Inc. · $TNGX
$572K Total Value
27,000 Shares Traded
$21.2029 Price / Share
112,622 Shares Owned After
2026-04-02 Filing Date

Transaction Details

InsiderCrystal Adam
TitlePresident, R&D
CompanyTango Therapeutics, Inc.
TickerTNGX
Transaction TypeSale
Transaction Date2026-04-01
Shares Traded27,000
Price Per Share$21.2029
Total Value$572K
Filed Date2026-04-02
Accession Number0001193125-26-140874

Ownership Context

Shares Owned After Transaction112,622
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-140874

Other Insider Trades — TNGX

Other Trades by Crystal Adam

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TNGX — Tango Therapeutics, Inc. →

Track TNGX insider activity in real time on The Wire →

Get alerts when Crystal Adam files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:20 UTC

Want real-time data? Access The Wire for live sentiment tracking.